Boolean network modeling of β-cell apoptosis and insulin resistance in type 2 diabetes mellitus

BackgroundMajor alteration in lifestyle of human population has promoted Type 2 diabetes mellitus (T2DM) to the level of an epidemic. This metabolic disorder is characterized by insulin resistance and pancreatic β-cell dysfunction and apoptosis, triggered by endoplasmic reticulum (ER) stress, oxidative stress and cytokines. Computational modeling is necessary to consolidate information from various sources in order to obtain a comprehensive understanding of the pathogenesis of T2DM and to investigate possible interventions by performing in silico simulations.ResultsIn this paper, we propose a Boolean network model integrating the insulin resistance pathway with pancreatic β-cell apoptosis pathway which are responsible for T2DM. The model has five input signals, i.e. ER stress, oxidative stress, tumor necrosis factor α (TNF α), Fas ligand (FasL), and interleukin-6 (IL-6). We performed dynamical simulations using random order asynchronous update and with different combinations of the input signals. From the results, we observed that the proposed model made predictions that closely resemble the expression levels of genes in T2DM as reported in the literature.ConclusionThe proposed model can make predictions about expression levels of genes in T2DM that are in concordance with literature. Although experimental validation of the model is beyond the scope of this study, the model can be useful for understanding the aetiology of T2DM and discovery of therapeutic intervention for this prevalent complex disease. The files of our model and results are available at https://github.com/JieZheng-ShanghaiTech/boolean-t2dm.

[1]  J. Rossant,et al.  Modeling signaling‐dependent pluripotency with Boolean logic to predict cell fate transitions , 2018, Molecular systems biology.

[2]  K. Petersen,et al.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes , 2014, Nature.

[3]  John Calvin Reed,et al.  Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.

[4]  S. Kousteni FoxO1, the transcriptional chief of staff of energy metabolism. , 2012, Bone.

[5]  Nils Welsh,et al.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.

[6]  P. Strålfors,et al.  Inhibition of FOXO1 transcription factor in primary human adipocytes mimics the insulin-resistant state of type 2 diabetes. , 2018, The Biochemical journal.

[7]  I. Gout,et al.  The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.

[8]  J. Naggert,et al.  GLUT4 Defects in Adipose Tissue Are Early Signs of Metabolic Alterations in Alms1GT/GT, a Mouse Model for Obesity and Insulin Resistance , 2014, PloS one.

[9]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[10]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[11]  R. Korneluk,et al.  XIAP: Apoptotic brake and promising therapeutic target , 2001, Apoptosis.

[12]  S. Masoodi,et al.  Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. , 2015, World journal of diabetes.

[13]  E. Araki,et al.  Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells , 2002, Apoptosis.

[14]  Song Li,et al.  Boolean network simulations for life scientists , 2008, Source Code for Biology and Medicine.

[15]  Kathryn L. Lipson,et al.  Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. , 2006, Cell metabolism.

[16]  R. Perfetti,et al.  Role of caspases in the regulation of apoptotic pancreatic islet beta‐cells death , 2004, Journal of cellular physiology.

[17]  P. Ray,et al.  Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.

[18]  M. Donath Targeting inflammation in the treatment of type 2 diabetes: time to start , 2014, Nature Reviews Drug Discovery.

[19]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[20]  S. Toyokuni,et al.  Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. , 1999, Diabetes.

[21]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[22]  T Takahashi,et al.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis , 2001, EMBO reports.

[23]  R. Kulkarni,et al.  Tribbles 3 Mediates Endoplasmic Reticulum Stress-Induced Insulin Resistance in Skeletal Muscle , 2013, Nature Communications.

[24]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[25]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[26]  Zhiyong Cheng,et al.  Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. , 2011, Antioxidants & redox signaling.

[27]  S. Cohen,et al.  ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation. , 2013, Genes & development.

[28]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[29]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[30]  T. Aw,et al.  Gadd153 Sensitizes Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the Cellular Redox State , 2001, Molecular and Cellular Biology.

[31]  T. Hunter,et al.  Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.

[32]  L. Williams,et al.  Tumor necrosis factor α‐induced activation of c‐jun N‐terminal kinase is mediated by TRAF2 , 1997, The EMBO journal.

[33]  A. Shapiro,et al.  Interventional Strategies to Prevent β-Cell Apoptosis in Islet Transplantation , 2006, Diabetes.

[34]  Jongsoon Lee,et al.  The role of GSK3 in glucose homeostasis and the development of insulin resistance. , 2007, Diabetes research and clinical practice.

[35]  T. Zimmers,et al.  Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. , 2003, Diabetes.

[36]  D. Ron,et al.  CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. , 2004, Genes & development.

[37]  A. Marette,et al.  Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. , 2005, Endocrinology.

[38]  J. Flier,et al.  Attenuation of leptin and insulin signaling by SOCS proteins , 2006, Trends in Endocrinology & Metabolism.

[39]  R. Mooney,et al.  Interleukin-6 depletion selectively improves hepatic insulin action in obesity. , 2005, Endocrinology.

[40]  P. Vandenabeele,et al.  Toxic proteins released from mitochondria in cell death , 2004, Oncogene.

[41]  M. Donath,et al.  Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. , 2001, Diabetes.

[42]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[43]  Gunnar Cedersund,et al.  Insulin Signaling in Type 2 Diabetes , 2013, The Journal of Biological Chemistry.

[44]  A. Barthel,et al.  Novel concepts in insulin regulation of hepatic gluconeogenesis. , 2003, American journal of physiology. Endocrinology and metabolism.

[45]  S. Oyadomari,et al.  Roles of CHOP/GADD153 in endoplasmic reticulum stress , 2004, Cell Death and Differentiation.

[46]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[47]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[48]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[49]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[50]  Kevin A. Roth,et al.  Dysfunction and Death Proapoptotic BAX and BAK : A Requisite Gateway to Mitochondrial , 2014 .

[51]  H. Hayashi,et al.  TRB3, a novel ER stress‐inducible gene, is induced via ATF4–CHOP pathway and is involved in cell death , 2005, The EMBO journal.

[52]  Kamil Erguler,et al.  A mathematical model of the unfolded protein stress response reveals the decision mechanism for recovery, adaptation and apoptosis , 2013, BMC Systems Biology.

[53]  Christian Weyer,et al.  High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[54]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[55]  M. Akash,et al.  Tumor Necrosis Factor‐Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus , 2018, Journal of cellular biochemistry.

[56]  Réka Albert,et al.  Boolean modeling: a logic‐based dynamic approach for understanding signaling and regulatory networks and for making useful predictions , 2014, Wiley interdisciplinary reviews. Systems biology and medicine.

[57]  Anne Bertolotti,et al.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response , 2000, Nature Cell Biology.

[58]  D. Ron,et al.  Endoplasmic reticulum stress and the development of diabetes: a review. , 2002, Diabetes.

[59]  D. Eizirik,et al.  Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic beta cell dysfunction and apoptosis , 2010, Diabetologia.

[60]  G. Hortobagyi,et al.  IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway , 2007, Cell.

[61]  T. Tenev,et al.  IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms , 2005, Nature Cell Biology.

[62]  Mark Paich,et al.  A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual , 2018, PloS one.

[63]  T. Mandrup-Poulsen,et al.  A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis , 2001, Diabetologia.

[64]  S. Mudaliar,et al.  Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. , 2000, Diabetes.

[65]  D. Goeddel,et al.  TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.

[66]  F. Urano,et al.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.

[67]  T. Tomita Apoptosis in pancreatic β-islet cells in Type 2 diabetes. , 2016, Bosnian journal of basic medical sciences.

[68]  Xiaozhong Wang,et al.  Stress-Induced Phosphorylation and Activation of the Transcription Factor CHOP (GADD153) by p38 MAP Kinase , 1996, Science.

[69]  M. White,et al.  Regulation of glucose homeostasis through a XBP-1–FoxO1 interaction , 2011, Nature Medicine.

[70]  P. Cohen,et al.  The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.